Alefacept

Alefacept is an immunomodulator that is used to treat plaque psoriasis. It works by targeting a specific type of white blood cell called a T-lymphocyte, which plays a major role in psoriasis. Alefacept helps reduce inflammation and skin lesions, and may even help improve the overall appearance of the skin. It is usually given once a week for 12 weeks in the form of an injection.

Alefacept, also known by the brand name Amevive®, is a prescription medication classified as a biologic response modifier. It is used to treat moderate to severe chronic plaque psoriasis in adults who are candidates for phototherapy (light therapy) or systemic therapy (medication that affects the entire body).

Here's a breakdown of Alefacept's key aspects:

How it works:

  • Alefacept works by targeting and reducing the activity of T lymphocytes, a specific type of immune cell involved in the inflammatory response characteristic of psoriasis. By limiting the activity of these T cells, Alefacept helps to decrease inflammation and improve symptoms like scaling, redness, and thickening of the skin.

Administration:

  • Alefacept is administered as an injection under the skin (subcutaneously) by a healthcare professional.
  • The usual dosing schedule is a single injection followed by three more injections given at weekly intervals.
  • Treatment cycles may be repeated after 12 weeks, if necessary, based on the individual's response and doctor's recommendation.

Potential side effects:

  • As with any medication, Alefacept can cause side effects, some of which can be serious. It's crucial to be aware of these potential side effects and report any concerning symptoms to your doctor immediately. Common side effects include:
    • Injection site reactions: Pain, redness, swelling, itching, or burning at the injection site.
    • Headache, fever, chills, fatigue, and muscle aches.
    • Upper respiratory tract infections (like the common cold) and other infections due to the temporary suppression of the immune system.
    • Increased risk of serious infections in some individuals, especially those with weakened immune systems.

Important information:

  • Alefacept should only be used under the supervision and guidance of a qualified healthcare professional experienced in treating psoriasis.
  • It is not suitable for everyone and may interact with other medications.
  • Pregnancy and breastfeeding are contraindicated with Alefacept due to potential risks to the developing baby or infant.
  • Individuals with certain medical conditions, weakened immune systems, or a history of severe infections should not use Alefacept.

Remember:

  • While Alefacept can be an effective treatment for moderate to severe chronic plaque psoriasis, it's crucial to discuss all treatment options and potential side effects with your doctor to determine if it's the right course of treatment for you.
  • Adhere strictly to the prescribed dosage and schedule as directed by your doctor.
  • Report any concerning side effects to your doctor immediately for proper management and to ensure your safety.

 


 

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AA Selective immunosuppressants
External Links